Distinct responsibilities
Each company retains its own operating scope, expertise and accountability. The ecosystem is a coordinated structure, not a claim that every capability sits inside one legal entity.
Sourcing · Development · Manufacturing · Distribution
An Integrated Pharmaceutical Ecosystem Built Around Execution.
Aram Pharma, Jean Vichar, Lirok Pharma and Ti-One connect complementary capabilities across the pharmaceutical value chain while each company retains a distinct operating role.
REF. JV-ECO-001WHY THE ECOSYSTEM EXISTS
Pharmaceutical products move through multiple disciplines. Coordination reduces the gaps between them.
The ecosystem was developed to connect international sourcing and market knowledge with product development, manufacturing, specialized inhalation capability and nationwide distribution.
A pharmaceutical opportunity can fail at the handoff between supplier and product owner, between development and manufacturing, or between production and market delivery. The group structure is intended to make those transitions more visible and manageable.
This does not mean every project must use every company. It means partners can access the capability they need while benefiting from a broader organization that understands how sourcing, technical development, commercial production and distribution affect one another.
REF. JV-COMP-002COMPANIES & ROLES
Parent Company · Founded 1993
Aram Pharma
Aram Pharma is the foundation of the group’s pharmaceutical sourcing and market-development experience. Founded by Dr. H. Akhavan after decades in the pharmaceutical industry, the company imports, registers, markets and sells pharmaceutical products and has longstanding relationships with international API manufacturers.
Within the ecosystem, Aram Pharma helps identify products, APIs, technology partners and market opportunities that may benefit from local development, manufacturing or commercialization.
- Pharmaceutical import, registration and trade
- API sourcing and international supplier relationships
- Market and partnership development in Iran
- Commercial and scientific coordination
Development & Manufacturing · Established 2014
Jean Vichar
Jean Vichar is the group’s pharmaceutical development and manufacturing company. It supports programs across solid oral dosage forms, metered-dose inhalers and nasal spray systems, as well as CMO and CDMO pathways.
Its role is to convert a product opportunity into a defined technical and manufacturing program, from assessment and technology transfer through validation, commercial manufacture and packaging.
- Technical assessment and formulation support
- Technology transfer, scale-up and validation
- Commercial manufacturing and packaging
- CMO/CDMO and lifecycle support
Specialized Respiratory Manufacturing
Lirok Pharma
Lirok Pharma was established to develop and manufacture pharmaceutical products in dry powder inhaler formats. Its specialist focus on DPI formulation and production complements Jean Vichar’s metered-dose inhaler and nasal spray capabilities.
Through Lirok Pharma, the ecosystem can evaluate respiratory opportunities across multiple inhalation platforms rather than treating every product as the same technical challenge.
- Dry powder inhaler formulation and manufacture
- Respiratory product and device expertise
- DPI research and development capability
- Complementary inhalation platform within the group
Pharmaceutical Distribution
Ti-One
Ti-One is a pharmaceutical distribution company serving pharmacies, hospitals and treatment centers across Iran. Its activities include essential, specialty and super-specialty medicines, along with selected health, cosmetic and medical-supply products.
The company emphasizes accurate storage, warehousing, transport and timely delivery. Within the ecosystem, Ti-One connects manufacturing and commercialization plans to the practical requirements of domestic market supply.
- Nationwide pharmaceutical distribution
- Service to pharmacies and treatment centers
- Controlled warehousing and transportation
- Delivery planning and market execution
REF. JV-FLOW-003CONNECTED PRODUCT PATHWAY
01Identify & Source
Evaluate APIs, products, technologies and international partnership opportunities.
02Develop & Transfer
Define formulation, process, component, documentation and scale-up requirements.
03Validate & Manufacture
Prepare the process for controlled commercial production and packaging.
04Specialize
Use dedicated inhalation expertise where DPI or other respiratory platforms are required.
05Distribute & Support
Coordinate storage, delivery, market supply and continuing product needs.
REF. JV-OPERATE-004HOW THE GROUP WORKS
Fewer disconnected handoffs
Technical, commercial and supply information can move more coherently when the companies involved understand the wider product pathway.
One entry point, multiple capabilities
A partner can begin with Jean Vichar and be connected to the appropriate sourcing, manufacturing, inhalation or distribution team.
Long-term operating relationships
The objective is to support products through development, launch and continuing supply rather than limit engagement to a single transaction.
REF. JV-ENGAGE-005WHERE PARTNERS FIT
API manufacturers
Explore API supply, technical data exchange, product localization and long-term commercial relationships through Aram Pharma and Jean Vichar.
Pharmaceutical product owners
Evaluate technology transfer, contract development, local manufacturing, packaging and continuing supply programs.
Respiratory technology partners
Assess MDI, nasal spray or DPI opportunities through the group’s complementary inhalation platforms.
Healthcare suppliers
Discuss domestic distribution and market-delivery requirements with Ti-One where the product and channel fit its operating scope.
Start with the Opportunity
We will help identify which capability and company should lead the conversation.
Share the product, API, technology, manufacturing or distribution objective. The Jean Vichar team can direct the inquiry to the appropriate group function.
Contact Jean Vichar